"Eli Lilly Pioneers Direct-to-Consumer Telehealth Model for Obesity Drug Access"

Eli Lilly has launched a new website, LillyDirect, to connect patients with obesity drugs such as Zepbound and Mounjaro through telehealth services, allowing direct ordering of drugs from the company. While the initiative aims to make it easier for patients to access treatments, experts and organizations like the American College of Physicians have raised concerns about the lack of in-person visits and the potential for patients to be misinformed, emphasizing the importance of a patient-physician relationship in healthcare. Critics argue that this direct-to-consumer approach commodifies medicine and may not provide neutral, balanced care.